C-reactive protein induces M-CSF release and macrophage proliferation

Journal of Leukocyte Biology

Volumn 85, Issue 2, 2009, Pages 262-267

  Devaraj, Sridevi ^a   Yun, Jung Mi ^a   Duncan Staley, Catherine ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CRP; Inflammation; Mechanistic insights

Indexed keywords

C REACTIVE PROTEIN; CD32 ANTIGEN; CD64 ANTIGEN; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL PROLIFERATION; CELL SECRETION; CYTOKINE RELEASE; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

C-REACTIVE PROTEIN; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MODELS, IMMUNOLOGICAL; NF-KAPPA B; RECEPTORS, IGG; RNA, MESSENGER;

EID: 59649100589     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0808458     Document Type: Article

References (41)

1. Libby, P. (2007) Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr. Rev. 65, S140-S146.
2. Hansson, G. K., Robertson, A. K., Söderberg-Nauclér, C. (2006) Inflammation and atherosclerosis. Annu. Rev. Pathol. 1, 297-329.
3. Clinton, S. K., Underwood, R., Hayes, L., Sherman, M. L., Kufe, D. W., Libby, P. (1992) Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140, 301-316.
4. Watanabe, Y., Inaba, T., Shimano, H., Gotoda, T., Kawamura, M., Shiomi, M., Yazaki, Y., Yamada, N. (1997) Effect of macrophage colony stimulating factor on the advanced atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Horm. Metab. Res. 29, 507-509.
5. Donnelly, L. H., Bree, M. P., Hunter, S. E., Keith Jr., J. C., Schaub, R. G. (1997) Immunoreactive macrophage colony-stimulating factor is increased in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits after recombinant human macrophage colony-stimulating factor therapy. Mol. Reprod. Dev. 46, 92-95.
6. Watanabe, Y., Inaba, T., Gotoda, T., Harada, K., Shimada, M., Ohsuga, J., Kawamura, M., Yazaki, Y., Yamada, N. (1995) Role of macrophage colony-stimulating factor in the initial process of atherosclerosis. Ann. N. Y. Acad. Sci. 748, 357-364.
7. Haghighat, A., Weiss, D., Whalin, M. K., Cowan, D. P., Taylor, W. R. (2007) Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115, 2049-2054.
8. Qiao, J. H., Tripathi, J., Mishra, N. K., Cai, Y., Tripathi, S., Wang, X. P., Imes, S., Fishbein, M. C., Clinton, S. K., Libby, P., Lusis, A. J., Rajavashisth, T. B. (1997) Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol. 150, 1687-1699.
9. Smith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., Miyata, M. (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92, 8264-8268.
10. Shiba, Y., Takahashi, M., Yoshioka, T., Yajima, N., Morimoto, H., Izawa, A., Ise, H., Hatake, K., Motoyoshi, K., Ikeda, U. (2007) M-CSF accelerates neointimal proliferation in the early phase after vascular injury in mice. Arterioscler. Thromb. Vasc. Biol. 27, 283-289.
11. Bassuk, S. S., Rifai, N., Ridker, P. M. (2004) High-sensitivity C-reactive protein: clinical importance. Curr. Probl. Cardiol. 29, 439-493.
12. Verma, S., Devaraj, S., Jialal, I. (2006) Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 113, 2135-2150.
13. Wu, J., Stevenson, M. J., Brown, J. M., Grunz, E. A., Strawn, T. L., Fay, W. P. (2008) C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler. Thromb. Vasc. Biol. 28, 698-704.
14. Bisoendial, R. J., Kastelein, J. J., Stroes, E. S. (2007) C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis 195, e10-e18.
15. Singh, U., Devaraj, S., Vasquez-Vivar, J., Jialal, I. (2007) C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell. Cardiol. 43, 780-791.
16. Devaraj, S., Xu, D. Y., Jialal, I. (2003) C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 107, 398-404.
17. Singh, U., Dasu, M. R., Yancey, P. G., Afify, A., Devaraj, S., Jialal, I. (2008) Human C-reactive protein promotes oxidized low-density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J. Lipid Res. 49, 1015-1023.
18. Devaraj, S., Dasu, R., Singh, U., Rao, L. V., Jialal, I. (2008) CRP stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis, Epub ahead of print.
19. Du Clos, T. W., Zlock, L. T., Marnell, L. (1991) Definition of a C-reactive protein binding determinant on histones. J. Biol. Chem. 266, 2167-2171.
20. Dasu, M. R., Devaraj, S., Du Clos, T. W., Jialal, I. (2007) The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J. Lipid Res. 48, 509-512.
21. Devaraj, S., Venugopal, S., Jialal, I. (2006) Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis 184, 48-52.
22. Devaraj, S., Davis, B., Simon, S. I., Jialal, I. (2006) CRP promotes monocyte-endothelial cell adhesion via Fc γ receptors in human aortic endothelial cells under static and shear flow conditions. Am. J. Physiol. Heart Circ. Physiol. 291, H1170-H1176.
23. Devaraj, S., Cheung, A. T., Jialal, I., Griffen, S. C., Nguyen, D., Glaser, N., Aoki, T. (2007) Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56, 2790-2796.
24. Devaraj, S., Kumaresan, P. R., Jialal, I. (2004) Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J. Mol. Cell. Cardiol. 36, 405-410.
25. Tedgui, A., Mallat, Z. (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86, 515-581.
26. Rallidis, L. S., Zolindaki, M. G., Pentzeridis, P. C., Poulopoulos, K. P., Velissaridou, A. H., Apostolou, T. S. (2004) Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome. Heart 90, 25-29.
27. Rallidis, L. S., Zolindaki, M. G., Manioudaki, H. S., Laoutaris, N. P., Velissaridou, A. H., Papasteriadis, E. G. (2002) Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina. Clin. Cardiol. 25, 505-510.
28. Saitoh, T., Kishida, H., Tsukada, Y., Fukuma, Y., Sano, J., Yasutake, M., Fukuma, N., Kusama, Y., Hayakawa, H. (2000) Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J. Am. Coll. Cardiol. 35, 655-665.
29. Ikonomidis, I., Lekakis, J., Revela, I., Andreotti, F., Nihoyannopoulos, P. (2005) Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery disease. Eur. Heart J. 26, 1618-1624.
30. Kobayashi, S., Inoue, N., Ohashi, N., Terashima, M., Matsui, Y., Mori, T. (2003) Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of CRP. Arterioscler. Thromb. Vasc. Biol. 23, 1398-1404.
31. Ridker, P. M., Cook, N. (2004) Clinical usefulness of very high and very low levels of CRP across the full range of Framingham risk scores. Circulation 109, 1955-1959.
32. Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., Braunwald, E. (2005) Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352, 20-28.
33. Pepys, M. B., Hirschfield, G. M. (2003) C-reactive protein: a critical update. J. Clin. Invest. 111, 1805-1812.
34. Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Gallimore, J. R., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., Cobb, A. J., Ley, S. V., Aquilina, J. A., Robinson, C. V., Sharif, I., Gray, G. A., Sabin, C. A., Jenvey, M. C., Kolstoe, S. E., Thompson, D., Wood, S. P. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440, 1217-1221.
35. Schwedler, S. B., Amann, K., Wernicke, K., Krebs, A., Nauck, M., Wanner, C., Potempa, L. A., Galle, J. (2005) Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation 112, 1016-1023.
36. Rajavashisth, T. B., Yamada, H., Mishra, N. K. (1995) Transcriptional activation of the macrophage-colony stimulating factor gene by minimally modified LDL. Involvement of nuclear factor-κ B. Arterioscler. Thromb. Vasc. Biol. 15, 1591-1598.
37. Frangogiannis, N. G., Mendoza, L. H., Ren, G., Akrivakis, S., Jackson, P. L., Michael, L. H., Smith, C. W., Entman, M. L. (2003) MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype. Am. J. Physiol. Heart Circ. Physiol. 285, H483-H492.
38. Ratcliffe, N. R., Kennedy, S. M., Morganelli, P. M. (2001) Immunocyto-chemical detection of Fc [INSERT IMAGE]R in human atherosclerotic lesions. Immunol. Lett. 77, 169-174.
39. Ryu, J., Lee, C. W., Shin, J. A., Park, C. S., Kim, J. J., Park, S. J., Han, K. H. (2007) Fc γ RIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4. Cardiovasc. Res. 75, 555-565.
40. Williams, T. N., Zhang, C. X., Game, B. A., He, L., Huang, Y. (2004) C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[γ]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler. Thromb. Vasc. Biol. 24, 61-66.
41. Qin, H., Edberg, J. C., Gibson, A. W., Page, G. P., Teng, L., Kimberly, R. P. (2004) Differential gene expression modulated by the cytoplasmic domain of Fc γ RIa (CD64) α-chain. J. Immunol. 173, 6211-6219.